Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.64 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.64 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.41 |
| ▸ | FNTA | P49354 | 2/20 | 0.36 |
| ▸ | FNTB | P49356 | 2/20 | 0.36 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2530952 | 0.99 | PTGS1 (0.65) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL2534816 | 0.99 | PTGS1 (0.65) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL1503471 | 0.88 | PTGS1 (0.68) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL10490007 | 0.88 | PTGS1 (0.68) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL6257074 | 0.88 | PTGS1 (0.71) | PTGS1GSTK1GLO1NOD1FNTA | |
| Glutathione Ethyl Ester SCHEMBL7530345 | 0.85 | PTGS1 (0.71) | PTGS1GSTK1GLO1NOD1 | |
| Glutathione Ethyl Ester SCHEMBL9817298 | 0.85 | PTGS1 (0.71) | PTGS1GSTK1GLO1NOD1 | |
| Glutathione Ethyl Ester SCHEMBL680361 | 0.85 | PTGS1 (0.71) | PTGS1GSTK1GLO1NOD1 | |
| SCHEMBL2532429 | 0.85 | PTGS1 (0.53) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL12252220 | 0.85 | PTGS1 (0.64) | PTGS1GSTK1GLO1NOD1FNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090298782-A1 | Compounds for Delivering Amino Acids or Peptides with Antioxidant Activity into Mitochondria and Use Thereof | UNIVERSITY OF ROCHESTER (US) | 2009-12-03 | — | — | US | disclosed |
| US-7585846-B2 | Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof | UNIVERSITY OF ROCHESTER (US) | 2009-09-08 | — | — | US | disclosed |
| US-20090149540-A1 | Compositions and Methods for Attenuating Mitochondria-Mediated Cell Injury | UNIVERSITY OF ROCHESTER | 2009-06-11 | — | — | US | disclosed |
| US-20070099845-A1 | Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof | ROCHESTER, UNIVERSITY OF | 2007-05-03 | — | — | US | disclosed |
| EP-1691818-A4 | COMPOUNDS FOR DELIVERING AMINO ACIDS OR PEPTIDES WITH ANTIOXIDANT ACTIVITY INTO MITOCHONDRIA AND USE THEREOF | UNIV ROCHESTER (US) | 2007-01-24 | — | — | EP | disclosed |
| EP-1691818-A2 | COMPOUNDS FOR DELIVERING AMINO ACIDS OR PEPTIDES WITH ANTIOXIDANT ACTIVITY INTO MITOCHONDRIA AND USE THEREOF | University of Rochester (US) | 2006-08-23 | — | — | EP | disclosed |
| US-20060160748-A1 | Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof | ROCHESTER, UNIVERSITY OF | 2006-07-20 | — | — | US | disclosed |
| US-20060122267-A1 | Compositions and methods for attenuating mitochondria-mediated cell injury | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-06-08 | — | — | US | disclosed |
| WO-2005051978-A2 | COMPOUNDS FOR DELIVERING AMINO ACIDS OR PEPTIDES WITH ANTIOXIDANT ACTIVITY INTO MITOCHONDRIA AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2005-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099845-A1 | Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof | TXN2, GLS, PDF | PTGS1 640/4885GSTK1 227/4885GLO1 551/4885 |
| US-20090149540-A1 | Compositions and Methods for Attenuating Mitochondria-Mediated Cell Injury | SHMT2, TXN2, TXNRD2 | PTGS1 219/4885GSTK1 164/4885GLO1 273/4885 |
| US-20060160748-A1 | Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof | TXN2, TXNRD2, HSPA9 | PTGS1 667/4885GSTK1 217/4885GLO1 576/4885 |
| US-20090298782-A1 | Compounds for Delivering Amino Acids or Peptides with Antioxidant Activity into Mitochondria and Use Thereof | TXN2, TXNRD2, HSPA9 | PTGS1 667/4885GSTK1 217/4885GLO1 576/4885 |
| US-20060122267-A1 | Compositions and methods for attenuating mitochondria-mediated cell injury | SHMT2, TXN2, TXNRD2 | PTGS1 222/4885GSTK1 165/4885GLO1 276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.